ivosidenib
servier,spdr s&p biotech,ishares biotechnology
['tibsovo', 'ivosidenib', '$ibb', '$xbi', 'servier']
servier presents updated results for ivosidenib (tibsovo ) in idh1-mutated relapsed/refractory myelodysplastic syndromes at the 2023 european hematology association (eha) congress. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt